Messaging to increase public support for naloxone distribution policies in the United States: Results from a randomized survey experiment

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Bachhuber, Marcus A ^a,b   McGinty, Emma E ^c   Kennedy Hendricks, Alene ^c   Niederdeppe, Jeff ^d   Barry, Colleen L ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE; OPIATE; NARCOTIC ANTAGONIST;

ARTICLE; CONTROLLED STUDY; DRUG INFORMATION; DRUG LEGISLATION; DRUG OVERDOSE; DRUG USE; EXPERIMENTAL STUDY; FAMILY RELATION; FRIEND; HEALTH CARE POLICY; HEALTH SURVEY; INFORMATION DISSEMINATION; INTERNET; LOGISTIC REGRESSION ANALYSIS; MEDICAL CARE; NARRATIVE; RANDOMIZATION; SOCIAL SUPPORT; STATISTICAL MODEL; UNITED STATES; ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; FEMALE; HUMAN; MALE; MIDDLE AGED; PUBLIC OPINION; QUESTIONNAIRE; SUPPLY AND DISTRIBUTION;

ADOLESCENT; ADULT; AGED; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; PUBLIC OPINION; RANDOM ALLOCATION; SURVEYS AND QUESTIONNAIRES;

EID: 84938826081     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130050     Document Type: Article

References (49)

1. Hedegaard H, Chen LH, Warner M. Drug-poisoning deaths involving heroin: United States, 2000-2013. NCHS Data Brief 2015 Mar;(190:) :1-7. PMID: 25932890
2. Dasgupta N, Creppage K, Austin A, Ringwalt C, Sanford C, Proescholdbell SK. Observed transition from opioid analgesic deaths toward heroin. Drug Alcohol Depend 2014 Dec 1; 145:238-41. doi: 10. 1016/j.drugalcdep.2014.10.005 PMID: 25456574
3. Rudd RA, Paulozzi LJ, Bauer MJ, Burleson RW, Carlson RE, Dao D, et al. Increases in heroin overdose deaths-28 States, 2010 to 2012. MMWR Morb Mortal Wkly Rep 2014 Oct 3; 63(39):849-54. PMID: 25275328
4. Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry 2014 Jul 1; 71(7):821-6. doi: 10.1001/jamapsychiatry.2014.366 PMID: 24871348
5. Trust for America's Health. Prescription Drug Abuse: Strategies to Stop the Epidemic 2013. Washington, DC; 2013 Oct.
6. Strang J, Darke S, Hall W, Farrell M, Ali R. Heroin overdose: the case for take-home naloxone. BMJ 1996 Jun 8; 312(7044):1435-6. PMID: 8664611
7. Doe-Simkins M, Walley AY, Epstein A, Moyer P. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health 2009 May; 99(5):788-91. doi: 10.2105/AJPH.2008.146647 PMID: 19363214
8. Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 2006; 25(3):89-96. PMID: 16956873
9. Piper TM, Stancliff S, Rudenstine S, Sherman S, Nandi V, Clear A, et al. Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse 2008; 43(7):858-70. doi: 10. 1080/10826080701801261 PMID: 18570021
10. Seal KH, Thawley R, Gee L, Bamberger J, Kral AH, Ciccarone D, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health 2005 Jun; 82(2):303-11. PMID: 15872192
11. Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy 2009 Mar; 20(2):131-6. doi: 10.1016/j.drugpo.2008.03.002 PMID: 18434126
12. Wagner KD, Valente TW, Casanova M, Partovi SM, Mendenhall BM, Hundley JH, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy 2010 May; 21(3):186-93. doi: 10.1016/j.drugpo.2009.01.003 PMID: 19268564
13. Albert S, Brason FW, Sanford CK, Dasgupta N, Graham J, Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med 2011 Jun; 12 Suppl 2:S77-S85. doi: 10. 1111/j.1526-4637.2011.01128.x PMID: 21668761
14. Walley AY, Doe-Simkins M, Quinn E, Pierce C, Xuan Z, Ozonoff A. Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat 2013 Feb; 44(2):241-7. doi: 10.1016/j.jsat.2012.07.004 PMID: 22980450
15. Green TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction 2008 Jun; 103(6):979-89. doi: 10.1111/j.1360-0443.2008.02182.x PMID: 18422830
16. Enteen L, Bauer J, McLean R, Wheeler E, Huriaux E, Kral AH, et al. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health 2010 Dec; 87(6):931-41. doi: 10.1007/s11524-010-9495-8 PMID: 20967505
17. Community-based opioid overdose prevention programs providing naloxone-United States, 2010. MMWR Morb Mortal Wkly Rep 2012 Feb 17; 61(6):101-5. PMID: 22337174
18. Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 2013; 346:f174. doi: 10.1136/bmj.f174 PMID: 23372174
19. Davis CS, Ruiz S, Glynn P, Picariello G, Walley AY. Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. Am J Public Health 2014 Aug; 104(8):e7-e9. doi: 10.2105/AJPH.2014.302062 PMID: 24922133
20. Ray B, O'Donnell D, Kahre K. Police officer attitudes towards intranasal naloxone training. Drug Alcohol Depend 2015 Jan 1; 146:107-10. doi: 10.1016/j.drugalcdep.2014.10.026 PMID: 25468814
21. Bazazi AR, Zaller ND, Fu JJ, Rich JD. Preventing opiate overdose deaths: examining objections to take-home naloxone. J Health Care Poor Underserved 2010 Nov; 21(4):1108-13. doi: 10.1353/hpu.2010.0935 PMID: 21099064
22. Beletsky L, Rich JD, Walley AY. Prevention of fatal opioid overdose. JAMA 2012 Nov 14; 308 (18):1863-4. doi: 10.1001/jama.2012.14205 PMID: 23150005
23. Tobin KE, Davey MA, Latkin CA. Calling emergency medical services during drug overdose: an examination of individual, social and setting correlates. Addiction 2005 Mar; 100(3):397-404. PMID: 15733253
24. Davidson PJ, McLean RL, Kral AH, Gleghorn AA, Edlin BR, Moss AR. Fatal heroin-related overdose in San Francisco, 1997-2000: a case for targeted intervention. J Urban Health 2003 Jun; 80(2):261-73. PMID: 12791802
25. Burris S, Beletsky L, Castagna C, Casey C, Colin C, McLaughlin JM. Stopping an invisible epidemic: Legal issues in the provision of naloxone to prevent opioid overdose. Drexel Law Review 2009; 1 (2):273-339.
26. Hewlett L, Wermeling DP. Survey of naloxone legal status in opioid overdose prevention and treatment. J Opioid Manag 2013 Sep; 9(5):369-77. doi: 10.5055/jom.2013.0179 PMID: 24353049
27. Beletsky L, Ruthazer R, Macalino GE, Rich JD, Tan L, Burris S. Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. J Urban Health 2007 Jan; 84(1):126-36. PMID: 17146712
28. The Network for Public Health Law. Legal interventions to reduce overdose mortality: Naloxone access and overdose Good Samaritan laws. St. Paul, MN; 2014 Nov. http://www.networkforphl.org/-asset/qz5pvn/network-naloxone-10-4.pdf
29. Davis CS, Southwell JK, Niehaus VR, Walley AY, Dailey MW. Emergency medical services naloxone access: a national systematic legal review. Acad Emerg Med 2014 Oct; 21(10):1173-7. doi: 10.1111/acem.12485 PMID: 25308142
30. Kimber J, Copeland L, Hickman M, Macleod J, McKenzie J, De AD, et al. Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ 2010; 341:c3172. doi: 10.1136/bmj.c3172 PMID: 20595255
31. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009;(3:) :CD002209.
32. Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014; 2:CD002207.
33. MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ 2012; 345:e5945. doi: 10.1136/bmj.e5945 PMID: 23038795
34. Barry CL, McGinty EE, Pescosolido BA, Goldman HH. Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness. Psychiatr Serv 2014 Oct; 65 (10):1269-72. doi: 10.1176/appi.ps.201400140 PMID: 25270497
35. Burstein P. The impact of public opinion on public policy: A review and an agenda. Polit Res Quart 2003 Mar 1; 56(1):29-40.
36. Morone JA. Enemies of the people: the moral dimension to public health. J Health Polit Policy Law 1997 Aug; 22(4):993-1020. PMID: 9334916
37. O'Keefe DJ. How to handle opposing arguments in persuasive messages: A meta-analytic review of the effects of one-sided and two-sided messages. Communications Yearbook 2015; 22:209-49.
38. Gross K. Framing Persuasive Appeals: Episodic and Thematic Framing, Emotional Response, and Policy Opinion. Political Psychology 2008 Apr 1; 29(2):169-92.
39. Kreuter MW, Green MC, Cappella JN, Slater MD, Wise ME, Storey D, et al. Narrative communication in cancer prevention and control: a framework to guide research and application. Ann Behav Med 2007 Jun; 33(3):221-35. PMID: 17600449
40. GfK. KnowledgePanel Design Summary. Palo Alto, CA; 2013. http://www.gfk.com/Documents/GfK-KnowledgePanel-Design-Summary.pdf
41. Squiers LB, Bann CM, Dolina SE, Tzeng J, McCormack L, Kamerow D. Prostate-specific antigen testing: men's responses to 2012 recommendation against screening. Am J Prev Med 2013 Aug; 45 (2):182-9. doi: 10.1016/j.amepre.2013.04.005 PMID: 23867025
42. Heckman CJ, Darlow S, Manne SL, Kashy DA, Munshi T. Correspondence and correlates of couples' skin cancer screening. JAMA Dermatol 2013 Jul; 149(7):825-30. doi: 10.1001/jamadermatol.2013.515 PMID: 23864084
43. Barry CL, Brescoll VL, Brownell KD, Schlesinger M. Obesity metaphors: how beliefs about the causes of obesity affect support for public policy. Milbank Q 2009 Mar; 87(1):7-47. doi: 10.1111/j.1468-0009. 2009.00546.x PMID: 19298414
44. Rothman EF, Edwards EM, Heeren T, Hingson RW. Adverse childhood experiences predict earlier age of drinking onset: results from a representative US sample of current or former drinkers. Pediatrics 2008 Aug; 122(2):e298-e304. doi: 10.1542/peds.2007-3412 PMID: 18676515
45. Davis MM, Fant K. Coverage of vaccines in private health plans: what does the public prefer? Health Aff (Millwood) 2005 May; 24(3):770-9. PMID: 15886172
46. Mutz D. Population-Based Survey Experiments. Princeton: Princeton University Press; 2011.
47. Des Jarlais DC, Paone D, Friedman SR, Peyser N, Newman RG. Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs. Am J Public Health 1995 Nov; 85(11):1577-84. PMID: 7485676
48. Burris S, Strathdee SA. To serve and protect? Toward a better relationship between drug control policy and public health. AIDS 2006 Jan 2; 20(1):117-8. PMID: 16327327
49. Paone D, Des Jarlais DC, Gangloff R, Milliken J, Friedman SR. Syringe exchange: HIV prevention, key findings, and future directions. Int J Addict 1995; 30(12):1647-83. PMID: 8557411